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Chronic and Acute n-3 Polyunsaturated Fatty Acid (n-3 PUFA) Treat-
ments Have Divergent Effects on Cardiac Ion Channel Function
Xulin Xu, Min Jiang, Mark A. Wood, Clive M. Baunmgarten, Gea-Ny Tseng.
virginia commonwealth university, Richmond, VA, USA.
Background: Clinical studies suggest that dietary fish oil (FO) supplement
(containing n-3 PUFAs) has anti- or pro-arrhythmic effects in different patient
populations. The underlying mechanisms are not clear. Objectives: To com-
pare effects of chronic vs acute n-3 PUFA treatment on ion channel function
important for shaping cardiac action potential (AP) configuration/duration,
and to explore the underlying mechanisms. Methods: Left ventricular myocytes
(VMs) from adult rabbits or guinea pigs fed with FO (180 mg/kg n-3 PUFAs)
forR 4 weeks or age-matched control are used for patch clamping (AP & ionic
current evaluation) and confocal microscopy (protein distribution). Ventricular
membrane fractions are used for Western blotting (protein level quantification).
Channel-expressing COS-7 cells serve as an in vitromodel to test the effects of
chronic or acute n-3 PUFA treatment on cardiac channel function/expression.
Results: Chronic n-3 PUFA treatment increases ICaL but decreases Ito, IKr
and IKs. Correspondingly, AP plateau is elevated and duration is prolonged.
Mechanisms for the observed chronic effects include: (a) changes in posttrans-
lational modification involving caveolae-related signaling pathways (no change
in Cav1.2 protein level/ distribution but decrease in caveolin-3), and (b)
changes in membrane protein trafficking/stability (reduced Kv4.2 protein
level). Chronic COS-7 exposure to n-3 PUFA also reduces the protein level
of Kv4.2 & KCNQ1, although not Kv1.4, Kv4.3, KChIP2, KCNE1 or hERG.
Importantly, acute exposure of VMs to n-3 PUFA reduces ICaL but increases
IKs, thus offsetting the chronic effects. Conclusions: FO supplement impacts
on cardiac ion channel function by chronic/stable effects, superimposed with
acute effects following FO ingestion that can offset the chronic effects but de-
cline with time. Combination of these effects sets up a dynamic pattern of how
cardiac electrical activity is influenced by FO supplement.
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Acute Toxic Effects Of Fatty Acids
Evgenia I. Fedotova1, Alexey V. Berezhnov1, Valery P. Zinchenko1,
Vladimir V. Dynnik2.
1ICB RAS, Pushchino, Russian Federation, 2ITEB RAS, Pushchino,
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One of the main risk factors in the development of adiposity, type II diabetes,
and some cardiovascular diseases is a chronic increase in the level of lipids and
free fatty acids (FFA) circulating in the blood. In the acute variant, urgent mo-
bilization of FFA may cause cell death in ischemia/reperfusion and microvesic-
ular steatosis of the liver. It is believed that the main mechanism underlying the
cell death in the presence of toxic FFA (primarily palmitic acid and myristic
acid) levels is the mitochondrial energetics destabilization. But some data sug-
gest that FFA and their derivatives (acylCoAs or acylcarnitines) may activate
reticular Ca2þ channels.
In this work we showed that the major cause of cell death induced by the acute
toxic action of fatty acids is the destabilization of Ca2þ homeostasis of excitable
or nonexcitable cells, which is associated with the activation of sarcoendoplas-
mic reticulumCa2þ release channels (RyRand IP3).Under these conditions, the
contribution of the activation of L-type Ca2þ channels, NMDA channels, the
reversion of the Naþ/Ca2þexchanger of the plasmalemma of excitable cells
and the store-operated calcium channels (SOC) of nonexcitable cells is small.
In this case, mitochondria act as a Ca2þ buffer system, which is capable of ac-
cumulating Ca2þ until the deenergization of mitochondria and a fall of D4 due
to the inhibition of the energetics through AcylCoA or the exhaustion of the
Ca2þ capacity of mitochondria and the release of Ca2þ into the cytoplasm
(opening of mPTP) followed by the necrotic cell death.
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Themost common cause for cardiac side effects during therapy is drug-induced,
acquired long QT syndrome due to direct blockade of the cardiac potassium
channel hERG.However, antimony-based antileishmanial compounds and arse-
nic trioxide (As2O3), an anti-neoplastic drug, are pro-arrhythmic by an increase
in cardiac calcium currents. In the present study we investigated the molecular
mechanism(s) underlying the increase in calcium currents observed on incuba-
tion with As2O3. Calcium currents were recorded in guinea pig ventricular
myocytes cultured overnight in the presence of As2O3. We found that arsenic-induced increases in calcium currents could be eliminated by co-incubation
with the phosphoinositide 3-kinase (PI3K) inhibitor LY294002. Similarly,
As2O3 effects could be abolished by incubation with wortmannin, a structurally
different PI3K inhibitor. When isoform-specific PI3K activities were evaluated
in cardiomyocytes, we found PI3Ka to bemost active. However, PI3Ka activity
was not altered on incubationwith As2O3. Inmarked contrast, the lipid phospha-
tase PTEN which degrades PI3K-produced PIP3, was oxidized on incubation
with As2O3 as indicated onWestern blots by the appearance of a fast migrating,
inactive protein form. In line with this observation, intracellular applied PIP3
was able to increase cardiac calcium currents in guinea pig ventricularmyocytes.
This effect was specific and could not be observed upon intracellular application
of PIP2. Furthermore, As2O3-induced increases of calcium currents were not
abolished by inhibition of PKB/Akt, an important downstream kinase activated
byPIP3, but instead appeared to require PKCand c-Src function. Taken together,
our experiments establish the lipid phosphatase PTEN as a crucial target for
oxidative inactivation by As2O3.We propose that an altered gain in PIP3-depen-
dent cell signaling is responsible for the pro-arrhythmic increase in cardiac
calcium currents seen with anti-neoplastic As2O3 during therapy.
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Can Pharmacological Openers Of M-type Potassium Channels Overcome
Receptor-mediated Channel Inhibition?
John E. Linley, Nikita Gamper.
University of Leeds, Leeds, United Kingdom.
M type potassium channels composed of KCNQ2/Q3 subunits are expressed in
damage-sensing (nociceptive) afferent nerves where they act as a break on neu-
ronal firing.G-protein-coupled receptor induced inhibition ofM channels occurs
in inflammation and causes hyperoverexcitability of sensory neurons, and can
producepotentially leading to pain. Pharmacological M channel openers are
therefore attractive candidates for pain management, however, it is unclear
whether these openers will be effective for receptor-inhibited channels. Down-
stream of Gq/11-coupled receptor activation, M channels can be independently
inhibited by either a drop in membrane PIP2 or by Ca
2þ/calmodulin. Using the
whole cell patch clamp we have therefore investigated the extent to which phar-
macological openers of M channels can overcome channel inhibition by PIP2
depletion or elevated cytosolic Ca2þ.
In CHO cells overexpressing KCNQ2/Q3 and calmodulin ([Ca2þ]i ¼ 1uM), M
current (IM) measured at 0mV was 4.5 fold smaller than controls (no calmod-
ulin, 50nM Ca2þ). The M channel opener flupirtine (10uM) produced a 2.3 fold
increase in IM compared with a 1.5 fold increase in controls (n ¼ 12, p<0.01).
Similarly another opener, zinc pyrithione (10uM), produced a 3.2 fold increase
in IM compared with 1.5 fold in controls (n ¼ 10, p<0.01).
In cells overexpressing a phosphoinositide 5’ phosphatase which depletes
membrane PIP2, M current was 6.7 fold smaller than controls. However, in con-
trast to Ca2þ/calmodulin-inhibited M channels, flupirtine and hydrogen perox-
ide (a non-specific M channel opener) produced a similar degree of activation
to controls resulting in stimulated currents which were still 3.6 fold (H2O2) and
3.2 fold (flupirtine) smaller than in unstimulated control cells.
Our data suggest that the therapeutic potential of M channel openers in the
treatment of inflammatory pain may be limited and may depend on the nature
of the second messengers involved.
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One of the best established functions of proton channels is facilitating NADPH
oxidase activity in phagocytes. NADPH oxidase moves electrons across the
membrane, leaving protons in the cytoplasm. Proton channels extrude most of
this acid, simultaneously compensating for the electrogenic action of the oxidase
and preventing cytoplasmic acidification. Agonists that activate NADPH oxi-
dase also produce an ‘‘enhanced gatingmode’’ in proton channels, characterized
by faster activation, increased conductance, and a negative shift of the gH-V re-
lationship, all of which increase the likelihood of proton channel opening. The
enhanced gating mode is the result of PKC activity (Morgan et al, 2007, J. Phys-
iol. 579:327-344).We assessed proton channel responses in a murine B cell line,
LK35.2. Nontransfected LK35.2 cells have no detectable proton current; cells
transfected with the human proton channel gene, HVCN1, have proton currents
that respond to PMAand the PKC inhibitor,GF109203X (GFX),when studied in
perforated-patch configuration. The response of proton currents in these cells to
PMA or GFXwas qualitatively like that of native leukocytes, but smaller in am-
plitude. In contrast, there was no detectable PMA response of human or murine
proton channels expressed in HEK-293 or COS-7 cells (Musset et al, 2008,
